SEC Tracker
Get the app

Akebia Therapeutics AKBA

Akebia Therapeutics: reports an exchange listing deficiency notice

Form
8-K
Filed
Importance
Routine
  • Reports an exchange listing deficiency notice (3.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Akebia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.